3.8 Article

Confounding

Journal

NEPHRON CLINICAL PRACTICE
Volume 116, Issue 2, Pages C143-C147

Publisher

KARGER
DOI: 10.1159/000315883

Keywords

Epidemiology; Confounding; Nephrology; Bias; Confounding by indication; Causality; Associations

Ask authors/readers for more resources

In confounding, the effect of the exposure of interest is mixed with the effect of another variable. It is important to identify relevant confounders and remove the confounding effect as much as possible. There are three criteria that need to be fulfilled to determine whether a variable could be considered a potential confounder. The first criterion is that the variable needs to be associated with the exposure. The second criterion is that the variable needs to be associated with the outcome or disease. The third criterion is that the variable should not be an intermediate variable in the causal pathway between exposure and outcome. Only if all the criteria are fulfilled is the variable under question a confounder. If one incorrectly adjusts for a variable that is not a confounder, one risks overadjustment or adjustment for spurious associations. Confounders can be prevented from entering the study, during the design of a study, or if this is not possible, one can try to remove it during the analysis phase. Copyright (C) 2010 S. Karger AG, Basel

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

3.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Urology & Nephrology

Technique failure in peritoneal dialysis: Modifiable causes and patient-specific risk factors

Anna A. Bonenkamp, Anita van Eck van der Sluijs, Friedo W. Dekker, Dirk G. Struijk, Carola Wh de Fijter, Yolande M. Vermeeren, Frans J. van Ittersum, Marianne C. Verhaar, Brigit C. van Jaarsveld, Alferso C. Abrahams

Summary: This study aimed to identify modifiable causes and risk factors of technique failure in peritoneal dialysis. Results showed that infections, leakage, and catheter problems were important causes of technique failure. APD use was associated with a lower risk of technique failure.

PERITONEAL DIALYSIS INTERNATIONAL (2023)

Article Transplantation

Validity and reliability of the Patient-Reported Outcomes Measurement Information System (PROMIS®) using computerized adaptive testing in patients with advanced chronic kidney disease

Esmee M. van der Willik, Fenna van Breda, Brigit C. van Jaarsveld, Marlon van de Putte, Isabelle W. Jetten, Friedo W. Dekker, Yvette Meuleman, Frans J. van Ittersum, Caroline B. Terwee

Summary: This study compared the content, validity, and reliability of PROMIS CATs and SF-12 in patients with chronic kidney disease. The results showed that PROMIS CATs had sufficient construct validity and test-retest reliability, and had a lower minimal detectable change compared to SF-12. The study suggests the need for further research on the feasibility of PROMIS CATs in nephrology care.

NEPHROLOGY DIALYSIS TRANSPLANTATION (2023)

Article Transplantation

Removing race from the CKD-EPI equation and its impact on prognosis in a predominantly White European population

Edouard L. Fu, Josef Coresh, Morgan E. Grams, Catherine M. Clase, Carl-Gustaf Elinder, Julie Paik, Chava Ramspek, Lesley A. Inker, Andrew S. Levey, Friedo W. Dekker, Juan J. Carrero

Summary: Implementing the 2021 CKD-EPI equation in predominantly White European populations would slightly increase eGFR and reclassify a significant proportion of CKD patients to a higher eGFR category. eGFR by both equations strongly predicted outcomes.

NEPHROLOGY DIALYSIS TRANSPLANTATION (2023)

Review Urology & Nephrology

Donor obesity and weight gain after transplantation: two still overlooked threats to long-term graft survival

Mehmet Kanbay, Sidar Copur, Duygu Ucku, Carmine Zoccali

Summary: The effect of donor obesity on kidney transplantation success has been overlooked for a long time. Excessive body fat has been found to have deleterious effects on renal function and graft survival. However, there is a lack of clinical trials addressing weight loss in kidney donors and transplant patients.

CLINICAL KIDNEY JOURNAL (2023)

Review Cardiac & Cardiovascular Systems

Cardiovascular complications in chronic kidney disease: a review from the European Renal and Cardiovascular Medicine Working Group of the European Renal Association

Carmine Zoccali, Francesca Mallamaci, Marcin Adamczak, Rodrigo Bueno de Oliveira, Ziad A. Massy, Pantelis Sarafidis, Rajiv Agarwal, Patrick B. Mark, Peter Kotanko, Charles J. Ferro, Christoph Wanner, Michel Burnier, Raymond Vanholder, Andrzej Wiecek

Summary: Chronic kidney disease (CKD) is a progressive condition that increases the risk of cardiovascular diseases. Traditional and non-traditional risk factors contribute to the progression of cardiovascular complications in CKD patients. Arterial disease in CKD patients is characterized by calcification and vascular stiffness. Recent clinical trials have shown promising potential treatments for CKD patients, including hypoxia-inducible factor prolyl hydroxylase inhibitors, intravenous iron for treating anemia, and sodium/glucose cotransporter-2 inhibitors. However, more research is needed in this area.

CARDIOVASCULAR RESEARCH (2023)

Article Cardiac & Cardiovascular Systems

Innate Immunity System in Patients With Cardiovascular and Kidney Disease

Carmine Zoccali, Francesca Mallamaci

Summary: With a global burden of 844 million, chronic kidney disease (CKD) is now considered a public health priority. Low-grade systemic inflammation plays a crucial role in adverse cardiovascular outcomes in CKD patients. Various factors, including cellular senescence, gut microbiota-dependent immune activation, lipoprotein modifications, and neuroimmune interactions, contribute to the unique severity of inflammation in CKD.

CIRCULATION RESEARCH (2023)

Editorial Material Cardiac & Cardiovascular Systems

The cardiovascular-renal link and the health burden of kidney failure

Carmine Zoccali, Francesca Mallamaci

EUROPEAN HEART JOURNAL (2023)

Review Medicine, General & Internal

Social isolation and loneliness: Undervalued risk factors for disease states and mortality

Mehmet Kanbay, Cem Tanriover, Sidar Copur, Ibrahim B. B. Peltek, Ali Mutlu, Francesca Mallamaci, Carmine Zoccali

Summary: Social isolation and loneliness are often overlooked conditions that have a negative impact on quality of life, overall health, and mortality. This review discusses the health consequences of these conditions, including potential causes, pathophysiological processes, associations with non-communicable diseases, and effects on health-related behaviors. It also explores current and novel management strategies. Healthcare professionals should be knowledgeable about social isolation and loneliness, thoroughly assess patients, and provide education and treatment options through shared decision-making. Further research is needed to better understand the underlying mechanisms and improve treatment strategies for these conditions.

EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2023)

Review Medicine, General & Internal

Physical exercise in kidney disease: A commonly undervalued treatment modality

Mehmet Kanbay, Sidar Copur, Abdullah B. Yildiz, Cem Tanriover, Francesca Mallamaci, Carmine Zoccali

Summary: Physical exercise plays a crucial role in improving multiple pathophysiological mechanisms and the quality of life for patients with chronic kidney disease (CKD). However, its direct impact on kidney function remains uncertain and further research is needed.

EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2023)

Article Urology & Nephrology

Are there sex differences in cardiovascular outcomes in non-dialysis CKD patients?

Pasquale Fabio Provenzano, Grazia Caridi, Giovanna Parlongo, Daniela Leonardis, Elvira Puntorieri, Giovanni Tripepi, Carmine Zoccali, Francesca Mallamaci

Summary: This study investigated the sex differences in cardiovascular risk and outcomes in CKD patients not on dialysis, and found that male patients had a higher risk of cardiovascular events compared to female patients.

CLINICAL KIDNEY JOURNAL (2023)

Article Urology & Nephrology

Venous bicarbonate and CKD progression: a longitudinal analysis by the group-based trajectory model

Graziella D'Arrigo, Mercedes Gori, Daniela Leonardis, Giovanni Tripepi, Francesca Mallamaci, Carmine Zoccali

Summary: This study found that higher bicarbonate trajectories were associated with a lower risk of adverse renal outcomes in CKD patients, suggesting that maintaining higher bicarbonate levels may benefit patients with CKD. However, further high-quality randomized trials are needed to confirm these findings and recommend bicarbonate supplementation as a strategy to delay CKD progression.

CLINICAL KIDNEY JOURNAL (2023)

Review Urology & Nephrology

Kidney biopsy in diabetic kidney disease. Yes, but in very selected cases

Carmine Zoccali

Summary: The debate on kidney biopsy in diabetic kidney disease (DKD) is multifaceted. One side argues for its broader application, citing precise diagnostic data and personalized treatment plans, while the other side opposes it, pointing out insufficient evidence, resource constraints, and potential risks. Both sides agree on the need for individualized patient care and open discussions between healthcare providers and patients.

CLINICAL KIDNEY JOURNAL (2023)

Review Urology & Nephrology

New trials in resistant hypertension: mixed blessing stories

Carmine Zoccali, Francesca Mallamaci, Luca De Nicola, Roberto Minutolo

Summary: Resistant hypertension is a condition associated with an increased risk of cardiovascular and renal complications. Current treatment options include non-pharmacological interventions and specific antihypertensive drug combinations. New compounds targeting different pathways have shown varied effectiveness in clinical trials. Further research is needed to improve our understanding and treatment of this condition.

CLINICAL KIDNEY JOURNAL (2023)

Review Urology & Nephrology

The long-term benefits of early intensive therapy in chronic diseases-the legacy effect

Carmine Zoccali, Francesca Mallamaci, Giovanni Tripepi, Edouard L. Fu, Vianda S. Stel, Friedo W. Dekker, Kitty J. Jager

Summary: The 'legacy effect' describes the long-term benefits of intensive therapy in reducing complications and mortality in chronic diseases. It is evident in studies related to chronic kidney disease (CKD) and highlights the importance of intensive treatment. However, the legacy effect is more pronounced in early-stage diabetes and less evident in long-term, established diabetes patients.

CLINICAL KIDNEY JOURNAL (2023)

Article Surgery

Understanding Health-Related Quality of Life in Kidney Transplant Recipients: The Role of Symptom Experience and Illness Perceptions

Yiman Wang, Paul van der Boog, Marc H. Hemmelder, Friedo W. Dekker, Aiko De Vries, Yvette Meuleman

Summary: The purpose of this article is to investigate the impact of symptom experience on health related quality of life (HRQOL) in kidney transplant recipients (KTRs) and whether illness perceptions mediated this impact. The findings suggest that worse symptom experiences could cause more unhelpful illness perceptions and consequently lead to lower HRQOL. The study highlights the importance of addressing symptom experiences and illness perceptions to improve HRQOL in kidney transplant recipients.

TRANSPLANT INTERNATIONAL (2023)

No Data Available